Agnieska Manka-Waluch

Suggest Changes
Learn More
PURPOSE We investigated the effect of repeated bone-targeted therapy with rhenium-188 hydroxyethylidenediphosphonate (HEDP) in patients with progressive, hormone-resistant prostate carcinoma and bone(More)
  • 1